Protocol - Motives for Using Medical Cannabis
- Alcohol - 30-Day Quantity and Frequency
- Alcohol - Lifetime Use Disorder
- Cigarette Nicotine Dependence
- Patterns of Substance Use - Adolescents
- Patterns of Substance Use - Adults - Binge-Drinking
- Screening and Severity of Substance Use Problems - Adolescents
- Screening and Severity of Substance Use Problems - Adults - Alcohol - Lifetime
- Screening and Severity of Substance Use Problems - Adults - Alcohol - Past 12 Months
- Screening and Severity of Substance Use Problems - Adults - Drugs
- Substances - 30-Day Frequency
- Substances - Lifetime Substance Use Disorder
- Tobacco - 30-Day Quantity and Frequency - Adolescent
- Tobacco - 30-Day Quantity and Frequency - Adult
Description
This questionnaire includes nine self-administered items from the International Cannabis Policy Study Survey, Wave 6 (2023). Respondents are asked about motivations for using medical cannabis and use of cannabis as a complement to or substitution for prescription and other drugs.
Specific Instructions
When there is an interest in capturing a broader range of cannabis products, the WG recommends considering replacing "marijuana" with "cannabis".
In the International Cannabis Policy Study (ICPS), Wave 6 (2023), respondents are only asked these questions if they answer the USE.RECENT question with a 2 (used marijuana more than 3 months ago but less than 12 months ago), 3 (used marijuana more than 30 days ago but less than 3 months ago), or 4 (used marijuana within the past 30 days). If investigators wish to include the USE.RECENT introductory question, it can be accessed in the General Cannabis Use protocol
Additionally, question 2 of this protocol has the condition that the respondent answers the EVER.TRY question from the ICPS (wave 6) with a 1 (Yes). If investigators wish to include the EVER.TRY introductory question, it can be accessed in the General Cannabis Use protocol.
Protocols may include terms and language that could be triggering to respondents. Investigators are encouraged to have resources in place to help respondents cope with triggers as needed.
Terminology related to substances, substance use, and recovery is fluid. Updates in protocol language may be appropriate based on circumstance. Suggestions for revision have been offered to update answer responses or other components of the questionnaires to account for the constantly changing landscape. These suggestions have not been tested or validated in research studies but may be considered by investigators to enhance relevance.
The Substance Use and Recovery WG notes that items can be assessed separately for THC and CBD products.
Availability
This protocol is freely available; permission not required for use.
Protocol
Motives - Alcohol, Tobacco, and Other Substances - Medical Cannabis
1. Do you use marijuana for medical reasons, 'recreational' reasons, or both?
By "medical marijuana user," we mean someone who uses marijuana only to manage a medical condition.
1[ ]Medical use only
2[ ]Recreational use only
3[ ]Both recreational and medical use
-77[ ]Don't know
-88[ ]Refuse to answer
2. Have you ever used marijuana to improve or manage symptoms for any of the following: SELECT ALL THAT APPLY.
1[ ]Anxiety (including phobia, obsessive-compulsive disorder or a panic disorder)
2[ ]Depression (including dysthymia)
3[ ]Post-traumatic stress disorder (PTSD) or traumatic event (e.g., abuse or loss)
4[ ]Bipolar disorder, mania, or borderline personality disorder
5[ ]Psychosis (e.g., paranoia, disorganized thinking, hearing voices that others can't hear) or dissociative identity disorder
6[ ]Schizophrenia
7[ ]Alcohol or other drug use
8[ ]Eating disorder
9[ ]ADD/ADHD
10[ ]Other significant emotional or mental health problem (we'll ask about pain, sleep and physical health symptoms on the next screen): _________
[ ] 11 I have never used marijuana for any of the above
[ ] -77 Don't know
[ ] -88 Refuse to answer
(Ask if Q2 = 1-10)
3. Do you currently use marijuana to improve or manage any of the following symptoms: SELECT ALL THAT APPLY
[ONLY SHOW RESPONSE OPTIONS SELECTED IN Q2]
[ ] 1 Anxiety (including phobia, obsessive-compulsive disorder or a panic disorder)
[ ] 2 Depression (including dysthymia)
[ ] 3 Post-traumatic stress disorder (PTSD) or traumatic event (e.g., abuse or loss)
[ ] 4 Bipolar disorder, mania, or borderline personality disorder
[ ] 5 Psychosis (e.g., paranoia, disorganized thinking, hearing voices that others can't hear) or dissociative identity disorder
[ ] 6 Schizophrenia
[ ] 7 Alcohol or other drug use
[ ] 8 Eating disorder
[ ] 9 ADD/ADHD
[ ] 10 Other significant emotional or mental health problem (we'll ask about pain, sleep and physical health symptoms on the next screen): _________
[ ] 11 I don't currently use marijuana to improve or manage the above symptoms.
[ ] -77 Don't know
[ ] -88 Refuse to answer
(Ask if Q2 = 1-10)
4. Is improving or managing mental health one of the main reasons you use cannabis?
[ ] 1 Yes
[ ] 2 No
[ ] -77 Don't know
[ ] -88 Refuse to answer
5. Have you ever used marijuana to improve or manage symptoms for any of the following: SELECT ALL THAT APPLY.
[ ] 1 Headaches/migraines
[ ] 2 Pain (including arthritis, neuropathy or premenstrual syndrome)
[ ] 3 Nausea/vomiting or chemotherapy symptoms
[ ] 4 Lack of appetite
[ ] 5 Seizures
[ ] 6 Muscle spasms
[ ] 7 To shrink tumors or treat cancer
[ ] 8 Problems sleeping
[ ] 9 Digestion/gastrointestinal issues (irritable bowel syndrome, inflammatory bowel disease, colitis, etc.)
[ ] 10 Fibromyalgia
[ ] 11 Other condition(s) (please specify):___________
[ ] 12 I have never used marijuana to treat or improve symptoms
[ ] -77 Don't know
[ ] -88 Refuse to answer
(Ask if Q5 = 1-11)
6. Do you currently use marijuana to improve or manage any of the following symptoms: SELECT ALL THAT APPLY
[ONLY SHOW RESPONSE OPTIONS SELECTED IN Q5]
[ ] 1 Headaches/migraines
[ ] 2 Pain (including arthritis, neuropathy or premenstrual syndrome)
[ ] 3 Nausea/vomiting or chemotherapy symptoms
[ ] 4 Lack of appetite
[ ] 5 Seizures
[ ] 6 Muscle spasms
[ ] 7 To shrink tumors or treat cancer
[ ] 8 Problems sleeping
[ ] 9 Digestion/gastrointestinal issues (irritable bowel syndrome, inflammatory bowel disease, colitis, etc.)
[ ] 10 Fibromyalgia
[ ] 11 Other condition(s) (please specify): ___________
[ ] 12 I don't currently use marijuana to improve or manage the above symptoms.
[ ] -77 Don't know
[ ] -88 Refuse to answer
(Ask if Q5 = 1-11)
7. Is improving or managing physical health one of the main reasons you use cannabis?
[ ] 1 Yes
[ ] 2 No
[ ] -77 Don't know
[ ] -88 Refuse to answer
(ASK IF Q5 = 1 or 2 [headaches or pain])
8. Have you ever used marijuana for pain relief, instead of using opioids or prescription pain medication?
[ ] 1 Yes
[ ] 2 No
[ ] -77 Don't know
[ ] -88 Refuse to answer
(ASK IF Q8 = 1)
9. Did you use marijuana for pain relief, instead of using opioids or prescription pain medication in the PAST 12 MONTHS?
[ ] 1 Yes
[ ] 2 No
[ ] -77 Don't know
[ ] -88 Refuse to answer
Personnel and Training Required
NoneEquipment Needs
NoneRequirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adolescent, Adult, Senior, Pregnancy
Participants
Adolescents and adults ages 16–65
Selection Rationale
The International Cannabis Policy Study Survey (ICPS) is a well-established international survey that has been administered since 2018 to monitor marijuana use in Canada, the United States, Australia, and New Zealand. Additionally, ICPS questions are based on questions from other well-established surveys (e.g., National Survey on Drug Use and Health [NSDUH]).
Language
English, French
Standards
Standard | Name | ID | Source |
---|
Derived Variables
None
Process and Review
Not Applicable
Protocol Name from Source
International Cannabis Policy Study (ICPS), Wave 6 (2023)
Source
Hammond, D., Goodman, S., Burkhalter, R., Corsetti, D., International Cannabis Policy Study Survey 2023 (Wave 6). September 2023Cannabis Sources – Medical Cannabis Use section, items CANNABIS.MED1, USE.MENTALHEALTH, USE.MENTALHEALTH.CURRENT, USE.MENTALHEALTH.MAIN, EVER.MED, EVER.MED.CURRENT, EVER.MED.MAIN, OPIOID.SUB, OPIOID.SUB2General References
Advanis Inc. (2022). The Canadian Cannabis Survey 2022: Methodological Report. Ottawa, Ontario, Canada: Health Canada. https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/124-21-e/POR124-21-Methodological_Report.pdf
Hammond, D., Goodman, S., Wadsworth, E., Freeman, T. P., Kilmer, B., Schauer, G., Pacula, R. L., & Hall, W. (2022). Trends in the use of cannabis products in Canada and the USA, 2018–2020: Findings from the International Cannabis Policy Study. International Journal on Drug Policy, 105, 103716. doi:10.1016/j.drugpo.2022.103716
Hammond, D., Goodman, S., Wadsworth, E., Rynard, V., Boudreau, C., & Hall, W. (2020). Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. International Journal on Drug Policy, 77, 102698. doi:10.1016/j.drugpo.2020.102698
Protocol ID
511101
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping |
---|
Measure Name
Motives - Alcohol, Tobacco, and Other Substances
Release Date
January 30, 2025
Definition
Instruments used separately to assess the motives (reasons) for drinking alcohol, smoking cigarettes, or using drugs.
Purpose
The purpose of this measure is to assess motives (reasons) for drinking alcohol, smoking cigarettes, or using drugs, by asking the respondent questions about his/her thoughts and motivations for such actions.
Keywords
addiction, alcohol, cigarette, conformity, coping, craving, desire, drugs, enhancement, illicit drugs, marijuana, Marijuana Motives Measure, MMM, nicotine, SAA, social, tobacco, urge, Substance-specific Intermediate Phenotypes, International Cannabis Policy Study, ICPS, opioid substitution, substance use, substance use disorder, SUD, tetrahydrocannabinol, THC, cannabidiol, CBD, addiction, substance use disorder and addiction
Measure Protocols
Protocol ID | Protocol Name |
---|---|
511101 | Motives for Using Medical Cannabis |